BDPT OTC
BioAdaptives Inc.
1W: -58.3%
1M: +87.8%
3M: +53.9%
YTD: -90.9%
1Y: -96.9%
3Y: -96.2%
5Y: -99.9%
$0.00
+0.00 (+5.00%)
Weekly Expected Move ±47.0%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0008-0.07
Volume7,746,076
Avg Volume17,893,775
Beta1.19
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJames Keener
Employees1
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2016-06-01
Websiteshopbioadaptives.com
2620 Regatta Drive
Las Vegas, NV 89128
US
Las Vegas, NV 89128
US
702 659 8829
About BioAdaptives Inc.
BioAdaptives, Inc. is a research and development company that develops and markets nutraceutical and dietary supplement products for humans and animals. Its products are derived from natural plant, fungi, and algal-based sources and include supplements for cognitive enhancement, weight management, and regenerative wellness.
Latest News
BioAdaptives® Outlines Xcellara™ Platform Strategy: Integrating Stem Cell Supply and Direction for Targeted Wellness
BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity
BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery
BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| FRISSORA MARK P | J-Other | 35,715 | — | 2026-09-01 |
| FRISSORA MARK P | J-Other | 15,152 | — | 2026-08-01 |
| FRISSORA MARK P | J-Other | 12,500 | — | 2026-07-01 |
| FRISSORA MARK P | J-Other | 4,717 | — | 2026-06-01 |
| FRISSORA MARK P | J-Other | 4,808 | — | 2026-05-01 |